| Autor: |
Mota LR; Post-Graduation Program in Interactive Processes of Systems and Organs, Institute of Health Sciences, Federal University of Bahia, Salvador, Brazil., de Melo Filho VM; School of Medicine of Bahia, Federal University of Bahia, Salvador, Brazil., de Castro LL; School of Medicine of Bahia, Federal University of Bahia, Salvador, Brazil., Garcia DF; Clinical Hospital of School of Medicine of Ribeirão Preto, USP, Salvador, Brazil., Terse-Ramos R; Department of Pediatrics, School of Medicine of Bahia, Federal University of Bahia, Avenida: Santa Luzia, 379/902. Horto Florestal, Salvador, Bahia, CEP: 40295-050, Brazil., Toralles MBP; Department of Pediatrics, School of Medicine of Bahia, Federal University of Bahia, Avenida: Santa Luzia, 379/902. Horto Florestal, Salvador, Bahia, CEP: 40295-050, Brazil., de Lima RLLF; Department of Biology, Institute of Biology, Federal University of Bahia, Salvador, Brazil., Souza EL; Department of Pediatrics, School of Medicine of Bahia, Federal University of Bahia, Avenida: Santa Luzia, 379/902. Horto Florestal, Salvador, Bahia, CEP: 40295-050, Brazil. souza.ednalucia@gmail.com. |
| Abstrakt: |
Knowledge of the genetic profile of Cystic Fibrosis (CF) contributes to a better understanding of the genotype/phenotype relationship, particularly in mixed populations such as in Brazil. To describe clinical data of CF patients with rare or not yet observed CFTR gene mutations in Brazil. It was a case series of CF patients followed-up at a referral center. Clinical and laboratory data were obtained through medical records. Molecular analysis of the mutations was performed by conventional methods and/or by next-generation sequencing. Ten patients were studied, seven had five pathogenic mutations without previous description in Brazil (Q1100P, Y109C, A107P, E1409K and K162E), one of which has not yet been reported in patients with CF (A107P). Among the seven patients, three (two siblings) had the second mutant allele of rare occurrence among Brazilians patients (G1069R and 2307insA). Three other patients also had at least one rare variant (V201M, S466X and G1069R). The age of the CF diagnosis ranged from 1 to 190 months in the ten cases and the main clinical manifestations were respiratory symptoms and difficulty in gaining weight. All but one patient presented clinical and/or laboratory data compatible with pancreatic insufficiency. The identification of rare or not yet described CFTR mutations in patients with CF in Brazil highlights the high genetic heterogeneity in this population. Knowledge of the genotypic profile of Brazilian CF patients can contribute to the development of specific mutation panels for the genetic investigation targeting each region of the country, as well as helping to understand the complex genotype/phenotype relationship, especially in mixed populations. |
Full text from SpringerLink